Holdings (as at 2025-08-28)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.95%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2025-08-28)
Security Name % of Net Assets
Alnylam Pharmaceuticals, Inc. 4.66%
Halozyme Therapeutics, Inc. 4.14%
argenx SE (ADR) 4.08%
ACADIA Pharmaceuticals Inc. 4.06%
Incyte Corporation 3.96%
BeOne Medicines Ltd. (ADR) 3.87%
Genmab A/S (ADR) 3.81%
Veracyte, Inc. 3.59%
Mettler-Toledo International Inc. 3.40%
Natera, Inc. 3.40%
Neurocrine Biosciences, Inc. 3.38%
United Therapeutics Corporation 3.38%
Gilead Sciences, Inc. 3.33%
Regeneron Pharmaceuticals, Inc. 3.32%
Krystal Biotech, Inc. 3.30%
Sarepta Therapeutics, Inc. 3.28%
Illumina, Inc. 3.24%
BioMarin Pharmaceutical Inc. 3.22%
Biogen Inc. 3.21%
Amgen Inc. 3.14%
Corcept Therapeutics Inc. 3.14%
Alkermes Plc 3.10%
Repligen Corporation 3.05%
Exact Sciences Corporation 2.94%
BioNTech SE (ADR) 2.93%
Exelixis, Inc. 2.74%
Waters Corporation 2.74%
Vertex Pharmaceuticals Incorporated 2.72%
Bruker Corporation 2.48%
Moderna, Inc. 2.36%
Dreyfus Government Cash Management (Institutional Shares) 0.06%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.